Joshua J Sumislawski1, Lucy Z Kornblith, Amanda S Conroy, Rachael A Callcut, Mitchell Jay Cohen. 1. From the Department of Surgery, Denver Health Medical Center, University of Colorado, Denver, Colorado (J.J.S., M.J.C); Department of Surgery, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, California (L.Z.K., A.S.C., R.A.C).
Abstract
BACKGROUND: Severely injured patients often progress from early hypocoagulable to normal and eventually hypercoagulable states, developing increased risk for venous thromboembolism (VTE). Prophylactic anticoagulation can decrease this risk, but its initiation is frequently delayed for extended periods due to concerns for bleeding. To facilitate timely introduction of VTE chemoprophylaxis, we characterized the transition from hypo- to hypercoagulability and hypothesized that trauma-induced coagulopathy resolves within 24 hours after injury. METHODS: Serial blood samples were collected prospectively from critically injured patients for 120 hours after arrival at an urban Level I trauma center. Extrinsic thromboelastometry maximum clot firmness was used to classify patients as hypocoagulable (HYPO, <49 mm), normocoagulable (NORM, 49-71 mm), or hypercoagulable (HYPER, >71 mm) at each time point. Changes in coagulability over hospital course, VTE occurrence, and timing of prophylaxis initiation were analyzed. RESULTS: 898 patients (median Injury Severity Score, 13; mortality, 12%; VTE, 8%) were enrolled. Upon arrival, 3% were HYPO (90% NORM, 7% HYPER), which increased to 9% at 6 hours before down-trending. Ninety-seven percent were NORM by 24 hours, and 53% were HYPER at 120 hours. Median maximum clot firmness began in the NORM range, up-trended gradually, and entered the HYPER range at 120 hours. Patients with traumatic brain injury (TBI) followed a similar course and were not more HYPO at any time point than those without TBI. Failure to initiate prophylaxis by 72 hours was predicted by TBI and associated with VTE development (27% vs 16%, p < 0.05). CONCLUSIONS: Regardless of injury pattern, trauma-induced coagulopathy largely resolves within 24 hours, after which hypercoagulability becomes increasingly more prevalent. Deferring initiation of chemoprophylaxis, which is often biased toward patients with intracranial injuries, is associated with VTE development. LEVEL OF EVIDENCE: Prognostic study, level III; Therapeutic, level IV.
BACKGROUND: Severely injured patients often progress from early hypocoagulable to normal and eventually hypercoagulable states, developing increased risk for venous thromboembolism (VTE). Prophylactic anticoagulation can decrease this risk, but its initiation is frequently delayed for extended periods due to concerns for bleeding. To facilitate timely introduction of VTE chemoprophylaxis, we characterized the transition from hypo- to hypercoagulability and hypothesized that trauma-induced coagulopathy resolves within 24 hours after injury. METHODS: Serial blood samples were collected prospectively from critically injured patients for 120 hours after arrival at an urban Level I trauma center. Extrinsic thromboelastometry maximum clot firmness was used to classify patients as hypocoagulable (HYPO, <49 mm), normocoagulable (NORM, 49-71 mm), or hypercoagulable (HYPER, >71 mm) at each time point. Changes in coagulability over hospital course, VTE occurrence, and timing of prophylaxis initiation were analyzed. RESULTS: 898 patients (median Injury Severity Score, 13; mortality, 12%; VTE, 8%) were enrolled. Upon arrival, 3% were HYPO (90% NORM, 7% HYPER), which increased to 9% at 6 hours before down-trending. Ninety-seven percent were NORM by 24 hours, and 53% were HYPER at 120 hours. Median maximum clot firmness began in the NORM range, up-trended gradually, and entered the HYPER range at 120 hours. Patients with traumatic brain injury (TBI) followed a similar course and were not more HYPO at any time point than those without TBI. Failure to initiate prophylaxis by 72 hours was predicted by TBI and associated with VTE development (27% vs 16%, p < 0.05). CONCLUSIONS: Regardless of injury pattern, trauma-induced coagulopathy largely resolves within 24 hours, after which hypercoagulability becomes increasingly more prevalent. Deferring initiation of chemoprophylaxis, which is often biased toward patients with intracranial injuries, is associated with VTE development. LEVEL OF EVIDENCE: Prognostic study, level III; Therapeutic, level IV.
Authors: Fernando Spencer Netto; Homer Tien; Jeremy Ng; Sarah Ortega; Sandro Scarpelini; Sandro B Rizoli; William Geerts Journal: Injury Date: 2011-06-30 Impact factor: 2.586
Authors: Jeffry L Kashuk; Ernest E Moore; Allison Sabel; Carlton Barnett; James Haenel; Tuan Le; Michael Pezold; Jerry Lawrence; Walter L Biffl; C Clay Cothren; Jeffrey L Johnson Journal: Surgery Date: 2009-10 Impact factor: 3.982
Authors: Scott G Louis; Misa Sato; Travis Geraci; Ross Anderson; S David Cho; Philbert Y Van; Jeffrey S Barton; Gordon M Riha; Samantha Underwood; Jerome Differding; Jennifer M Watters; Martin A Schreiber Journal: JAMA Surg Date: 2014-04 Impact factor: 14.766
Authors: James P Byrne; Stephanie A Mason; David Gomez; Christopher Hoeft; Haris Subacius; Wei Xiong; Melanie Neal; Farhad Pirouzmand; Avery B Nathens Journal: J Am Coll Surg Date: 2016-07-21 Impact factor: 6.113
Authors: Hunter B Moore; Ernest E Moore; Ioannis N Liras; Charles Wade; Benjamin R Huebner; Clay Cothren Burlew; Fredric M Pieracci; Angela Sauaia; Bryan A Cotton Journal: Am J Surg Date: 2017-09-18 Impact factor: 2.565
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Simon Gabriel Rodier; Marko Bukur; Samantha Moore; Spiros George Frangos; Manish Tandon; Charles Joseph DiMaggio; Patricia Ayoung-Chee; Gary Thomas Marshall Journal: Eur J Trauma Emerg Surg Date: 2019-08-30 Impact factor: 3.693
Authors: M Margaret Knudson; Ernest E Moore; Lucy Z Kornblith; Amy M Shui; Scott Brakenridge; Brandon R Bruns; Mark D Cipolle; Todd W Costantini; Bruce A Crookes; Elliott R Haut; Andrew J Kerwin; Laszlo N Kiraly; Lisa M Knowlton; Matthew J Martin; Michelle K McNutt; David J Milia; Alicia Mohr; Ram Nirula; Fredrick B Rogers; Thomas M Scalea; Sherry L Sixta; David A Spain; Charles E Wade; George C Velmahos Journal: JAMA Surg Date: 2022-02-09 Impact factor: 16.681
Authors: Julia R Coleman; Annika B Kay; Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Sarah Majercik; Mitchell J Cohen; Thomas White; Fredric M Pieracci Journal: Am J Surg Date: 2019-09-10 Impact factor: 2.565
Authors: Eric J Ley; Carlos V R Brown; Ernest E Moore; Jack A Sava; Kimberly Peck; David J Ciesla; Jason L Sperry; Anne G Rizzo; Nelson G Rosen; Karen J Brasel; Rosemary Kozar; Kenji Inaba; Matthew J Martin Journal: J Trauma Acute Care Surg Date: 2020-11 Impact factor: 3.313
Authors: Joseph F Rappold; Forest R Sheppard; Samuel P Carmichael Ii; Joseph Cuschieri; Eric Ley; Erika Rangel; Anupamaa J Seshadri; Christopher P Michetti Journal: Trauma Surg Acute Care Open Date: 2021-02-24